ArticleCancer letters2023

Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer.

Samrita Dogra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.